HIVE Earnings

HIVE reported its earnings on 2026-06-02, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was -0.28, surpassing the expected -0.21 by -33.33%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following HIVE's earnings announcement on 2026-06-02, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, HIVE's stock price tends to shift by an average of 8.4% in the 10 days leading up to earnings and -1.65% in the 10 days following, providing insight into potential market.

For 2027/Q1, analysts estimate HIVE's annual revenue to reach 113.88M, while the EPS is projected at -0.05. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HIVE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HIVE's stock price typically moves by 8.4% in the 10 days before its earnings and -1.65% in the 10 days after. For the upcoming 2027/Q1 earnings, analysts expect an EPS of -0.05 and revenue of 113.88M.

The earnings call summary highlights significant declines in key financial metrics: revenue down 10%, adjusted EBITDA down 25%, net income down 50%, and free cash flow down 20%. These declines, driven by lower cryptocurrency rewards, declining Bitcoin prices, and increased energy costs, indicate financial challenges. The absence of positive updates in operational, strategic, or risk areas, coupled with unclear management responses in the Q&A, further suggests a negative sentiment. The overall market reaction is expected to be negative, with potential stock price decline between -2% to -8%.